Family Voices News
What to know about the omicron variant of the coronavirus (Washington Post)
Omicron has sparked alarm among epidemiologists worried that the new variant’s mutations could make it more transmissible. Scientists are racing to learn more as new cases are confirmed. Read more here.
Will the Vaccines Stop Omicron? Scientists Are Racing to Find Out.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary. Read more here.
Washington Update November 17, 2021
On Monday, November 15, President Biden signed the bipartisan infrastructure bill into law. So where, you ask, do things stand with the Build Back Better reconciliation bill? Word on the street is that the House plans to vote on Build Back Better this week. The...
Washington Update November 10, 2021
Much negotiation continues on the details of the reconciliation bill. Last week saw several things being added to or taken away from the framework. Paid Medical leave is back in! Although it is only for 4 weeks total (initial proposal was 12 weeks), it is back in...
Cara Coleman, Family Voices’ Director of Public Policy and Advocacy, Receives Notre Dame Distinguished Service Award
On October 29, 2021, Cara Coleman (JD, MPH), Family Voices’ Director of Public Policy and Advocacy, was publicly celebrated in a series of University-sponsored private and public events—including one event before an audience of 80,000—as the current recipient of the...
Washington Update November 3, 2021
We have a framework! Last week the White House released the Build Back Better framework for reconciliation. Notably, the framework includes an invitation to share how the Build Back Better plan will affect CYSHCN and families. Take a look at it, and scroll to the...
Should my child get a coronavirus vaccine? Is it safe? Here’s what you should know. (Washington Post)
With millions of U.S. children eligible to receive a coronavirus vaccine, many health experts are urging parents and guardians to immunize their children — especially since the highly transmissible delta variant is the dominant strain in the United States. Read more...
Asesores de FDA recomiendan autorizar la vacuna Covid de Pfizer para niños de 5 a 11 años (La Opinion)
El paso siguiente es el de la decisión de la FDA sobre el uso de emergencia de la vacuna Covid-19 de Pfizer en niños de 5 a 11 años y se espera para el 1 de noviembre Leer más aquí.
States placing orders for pediatric vaccine; FDA authorization expected as soon as Friday, October 29 (Washington Post)
The Food and Drug Administration is aiming to grant emergency use authorization to the Pfizer-BioNTech coronavirus vaccine for children ages 5 to 11 on October 27, according to federal officials familiar with the plans. Read more here.
FDA advisory panel recommends Pfizer Covid-19 vaccine be authorized for children (STAT)
An advisory panel to the Food and Drug Administration voted in favor of authorizing the Covid-19 vaccine made by Pfizer and BioNTech for children ages 5 to 11. Read more here.
Encourage confidence to act